The O-Darwinian Hypothesis (OdH) proposes a paradigm shift: cancer is not just a disease but a potential macro-immune-adaptive response – a self-replicating algorithm that can be reprogrammed via 3D-printed AI-based p53 superproteins. Using hypothesis-generating methods (observation, deductive reasoning), the author presents two theoretical findings: a wireless 3D printed p53 molecular biochip and the bifocal (micro-/macroimmunological) nature of cancer cells. The basic argument: uncontrolled cell division may represent an evolutionary healing effort that requires deciphering, not just suppression. A workflow for the AI-assisted design of p53 (AlphaFold 3, MoluCAD, Blender) and bacterial delivery systems is described. Clinical translation remains speculative. experimental validation is required.
Import
The author questions whether cancer has been falsified by overspecialization. OdH sees cancer as a self-learning adaptive evolutionary process that can be tackled by artificially engineered p53 superproteins.
Cancer as biological fatalism
Typical oncology: cancer arises from mutations in cell cycle regulators (oncogenes activated, tumor suppressors such as p53 deactivated). p53 normally repairs DNA or triggers apoptosis. in cancer it is often deficient.
Cancer as biological creativity and 3D printed p53 based on artificial intelligence
OdH reframes uncontrolled division as an adaptive immune response. The author proposes to 3D print p53 “hyperproteins” using AI design (AlphaFold 3) and open source software (MoluCAD, Blender, Meshmixer) to create a wireless p53 molecular biochip that communicates with an AI algorithm (eg, ChatGPT) to guide tumor suppression. Synthetic biology (Fussenegger’s genetic CPU) and evolutionary medicine provide the theoretical backbone.
Immunological nature of cancer with a dual focus
OdH distinguishes micro-immunology (tumor immune evasion) from macro-immunology (cancer as a continuous non-pathological self-learning process over evolutionary timescales). AI-printed p53 could accelerate this macro-immunoadaptive dimension.
3D protein printing with an AI environment
The paper examines AI-based protein design (AlphaFold 3, RoseTTAFold) and 3D bioprinting. Recommended delivery: weakened Salmonella transfer of viral genomes and synthetic p53 to tumors (CAPPSID platform);
Clinical translation and limitations
This remains speculative. Confirmation bias is a risk. no experimental data are shown. Analogous to Einstein’s photon hypothesis, which took years to validate.
Future directions
Viability tests for p53 as an electrochemical biochip. statistical validation (α=0.05, p<0.05) for tumor inhibition. Interdisciplinary collaborations are needed.
conclusions
The doctrine of cancer as merely a fugitive division must be overcome. Cancer may be a self-replicating immunoadaptive algorithm whose “source code” – deciphered through 3D printed AI-based p53 superproteins – can be reprogrammed.
